Literature DB >> 21460325

Assessments of HIV drug resistance mutations in resource-limited settings.

Michael R Jordan.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21460325     DOI： 10.1093/cid/cir093

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  8 in total

1.  Monitoring of early warning indicators for HIV drug resistance in antiretroviral therapy clinics in Zimbabwe.

Authors:  J Dzangare; E Gonese; O Mugurungi; T Shamu; T Apollo; D E Bennett; K F Kelley; M R Jordan; C Chakanyuka; F Cham; R M Banda
Journal:  Clin Infect Dis       Date:  2012-05       Impact factor: 9.079

2.  Update on World Health Organization HIV drug resistance prevention and assessment strategy: 2004-2011.

Authors:  M R Jordan; D E Bennett; M A Wainberg; D Havlir; S Hammer; C Yang; L Morris; M Peeters; A M Wensing; N Parkin; J B Nachega; A Phillips; A De Luca; E Geng; A Calmy; E Raizes; P Sandstrom; C P Archibald; J Perriëns; C M McClure; S Y Hong; J H McMahon; N Dedes; D Sutherland; S Bertagnolio
Journal:  Clin Infect Dis       Date:  2012-05       Impact factor: 9.079

Review 3.  Systematic review of HIV drug resistance in Southeast Asia.

Authors:  Andrew B Trotter; Steven Y Hong; Padmini Srikantiah; Iyanthi Abeyewickreme; Silvia Bertagnolio; Michael R Jordan
Journal:  AIDS Rev       Date:  2013 Jul-Sep       Impact factor: 2.500

4.  HIV drug resistance early warning indicators in cohorts of individuals starting antiretroviral therapy between 2004 and 2009: World Health Organization global report from 50 countries.

Authors:  Diane E Bennett; Michael R Jordan; Silvia Bertagnolio; Steven Y Hong; Giovanni Ravasi; James H McMahon; Ahmed Saadani; Karen F Kelley
Journal:  Clin Infect Dis       Date:  2012-05       Impact factor: 9.079

5.  Prevalence of HIV Drug Resistance Mutations in HIV Type 1 Isolates in Antiretroviral Therapy Naïve Population from Northern India.

Authors:  S Sinha; H Ahmad; R C Shekhar; N Kumar; L Dar; J C Samantaray; S K Sharma; A Bhargava; R M Pandey; R L Mitsuyasu; J L Fahey
Journal:  AIDS Res Treat       Date:  2012-03-15

6.  Utilization of dried blood spot specimens can expedite nationwide surveillance of HIV drug resistance in resource-limited settings.

Authors:  Guoqing Zhang; Joshua DeVos; Sandra Medina-Moreno; Nicholas Wagar; Karidia Diallo; R Suzanne Beard; Du-Ping Zheng; Christine Mwachari; Carolyn Riwa; Boniface Jullu; Ngugi Evelyn Wangari; Mary S Kibona; Lucy W Ng'Ang'A; Elliot Raizes; Chunfu Yang
Journal:  PLoS One       Date:  2018-09-07       Impact factor: 3.240

7.  Results from implementing updated 2012 World Health Organization Guidance on early-warning indicators of HIV drug resistance in Zimbabwe.

Authors:  More Mungati; Mutsa Mhangara; Janet Dzangare; Owen Mugurungi; Tsitsi Apollo; Elizabeth Gonese; Peter H Kilmarx; Christine C Chakanyuka-Musanhu; Gerald Shambira; Mufuta Tshimanga
Journal:  J Epidemiol Res       Date:  2016

8.  HIV drug resistance early warning indicators in Namibia for public health action.

Authors:  Anna Jonas; Justice Gweshe; Milner Siboleka; Michael Deklerk; Michael Gawanab; Alfons Badi; Victor Sumbi; Dawn Pereko; Abraham Blom; Samson Mwinga; Michael R Jordan; Logan Jerger; Kiger Lau; Steven Y Hong
Journal:  PLoS One       Date:  2013-06-07       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.